French Building Stock News

Altarea (ENXTPA:ALTA) attracted fresh attention after its half year 2026 results showed net income and earnings per share from continuing operations higher than a year earlier, despite lower sales and alongside reaffirmed dividend guidance. See our latest analysis for Altarea. Altarea's recent half year earnings and reaffirmed €8.00 dividend guidance have come as the share price sits at €100.60, with a 30 day share price return of 3.18% but a 1 year total shareholder return that slipped...

Renault SA ( EPA:RNO ) just reported healthy earnings but the stock price didn't move much. Our analysis suggests that...

Investors signalled that they were pleased with Viridien Société anonyme's ( EPA:VIRI ) most recent earnings report...

Why Orange stock is back in focus after earnings and data centre deal Orange (ENXTPA:ORA) has moved into the spotlight after half year 2026 results showed a swing from loss to profit, alongside a new data centre joint venture aimed at serving AI and cloud demand in France. See our latest analysis for Orange. Orange’s recent earnings swing and the planned data centre joint venture arrive after a mixed share price run, with short term momentum still patchy but longer term total shareholder...

In late July 2026, bioMérieux S.A. reported half-year results showing sales of €1,964.6 million versus €2,043.8 million a year earlier, while net income rose to €226.1 million from €161 million and basic earnings per share from continuing operations increased to €1.92 from €1.36. The combination of lower sales yet higher earnings suggests meaningful efficiency gains or cost discipline that materially improved profitability for the period. We’ll now examine how this profitability improvement,...

TF1 (ENXTPA:TFI) reported half year 2026 results on 24 July, with sales of €993.4 million and net income of €50.7 million. Both figures were lower than the prior year period. See our latest analysis for TF1. Following the half year 2026 announcement, TF1’s latest share price of €7.02 reflects a mixed picture, with the share price return up 4.08% over 90 days but down 15.17% year to date, while the 5 year total shareholder return of 19.62% points to a more positive longer term outcome. If...

Euronext N.V. has reported its half‑year 2026 results, with sales of €1,030.93 million, revenue of €1,070.15 million, and net income of €411.18 million, all higher than the prior year period. The rise in basic earnings per share from continuing operations to €4.06 suggests earnings growth is outpacing sales, pointing to improved profitability and operating efficiency. We’ll now examine how this stronger first‑half profitability shapes Euronext’s existing investment narrative around revenue...

Central banks are easing away from aggressive tightening as inflation readings cool in several regions, which takes some pressure off funding costs for capital heavy sectors such as aerospace and defense. For investors, that creates a window where demand for security and critical infrastructure still matters, yet money is not getting steadily more expensive. This article highlights three Aerospace And Defense screener stocks that stand out on current fundamentals. The three aerospace and...

OVH Groupe stock has surged 109.1% year to date, yet the intrinsic value estimate using a Discounted Cash Flow (DCF) approach points to a level that is close to the current market price, and the broader valuation checks still lean on the expensive side. Year to date, OVH Groupe has gained 109.1%. This puts extra focus on whether the current share price already reflects most of the good news. The recent acquisition of French voice AI specialist Gladia may support long term growth...

Air Liquide has released its half-year 2026 results, reporting modest year-on-year increases in sales to €13,827.9 million and net income to €1,822.6 million, alongside slightly higher earnings per share. The company also committed over US$150 million to a new ultra-pure industrial gas facility in Idaho to support advanced semiconductor memory production, underlining its deepening role in supplying critical materials for AI-related chip manufacturing and reshoring efforts in the U.S. We’ll...

Edenred (ENXTPA:EDEN) has drawn fresh attention after agreeing to bring Abry Partners into Edenred Pay North America through a €75 million equivalent cash investment and a structure that gives Abry exposure to future equity value. See our latest analysis for Edenred. The Edenred share price has climbed sharply in recent months, with a 30 day share price return of 22.46% and a 90 day gain of 36.51%. The year to date share price return of 53.85% contrasts with a weaker 3 year total shareholder...

Capgemini earnings update and why the stock is in focus Capgemini (ENXTPA:CAP) has drawn fresh attention after reporting half year 2026 results. Sales reached €12,082 million compared with €11,107 million a year earlier, while net income and earnings per share declined over the same period. See our latest analysis for Capgemini. The earnings release has arrived at a time when Capgemini’s share price has shown a 17.46% 1 month share price return, yet the stock remains down 22.56% on a year to...

Diageo’s new US$1b cost cutting plan and the share price surge that followed has put the entire global spirits sector under a sharper spotlight. When a heavyweight publicly chases efficiency, it can pressure competitors’ margins, pricing and brand spending. That can create both blind spots and opportunities for investors. This article examines how that news may affect three stocks closely exposed to the same forces, and why that may be relevant for your portfolio decisions now. Constellation...

The European stock markets have recently experienced a positive momentum, with the STOXX Europe 600 Index reaching new highs driven by strong corporate earnings and improved sentiment in AI-related sectors. Investing in penny stocks, while often associated with smaller or newer companies, can still present unique growth opportunities despite being considered a niche area. By focusing on those with solid financial health and potential for growth, investors can uncover promising prospects...

The market for Bureau Veritas SA's ( EPA:BVI ) shares didn't move much after it posted weak earnings recently. We think...

The European markets have recently shown resilience, with the STOXX Europe 600 Index reaching new highs, driven by robust corporate earnings and a rebound in AI-related stocks. Amid this positive momentum, investors are keenly observing opportunities to identify stocks that may be trading below their estimated value due to market fluctuations or overlooked fundamentals.

Groupe SEB has expanded its U.S. professional business by integrating hospitality brands WMF and HEPP into the SEB Professional Culinary Division via La Brigade de Buyer Inc., effective since June 2026, to offer a comprehensive “Kitchen to Table” solution for hospitality clients nationwide. This move deepens SEB’s presence in the professional hospitality market by combining premium European tabletop and equipment brands with its modern New Jersey logistics hub and dedicated U.S. hospitality...

Today is shaping up negative for Hydrogen-Refueling-Solutions SA ( EPA:ALHRS ) shareholders, with the analysts...

TotalEnergies (ENXTPA:TTE) has returned to focus after it and partner Eni approved the Cronos gas field development in Cyprus, a new offshore LNG project that will supply Egyptian liquefaction facilities and European exports. See our latest analysis for TotalEnergies. At a latest share price of €73.80, TotalEnergies has pulled back slightly in the past week, with a 7 day share price return of a 2.68% decline, after a strong 30 day share price return of 9.90% and a year to date share price...

Ipsos (ENXTPA:IPS) has moved into a new leadership chapter, with the Board appointing long serving executive Kelly Beaver as Chief Executive Officer from July 31, 2026, replacing Jean Laurent Poitou. See our latest analysis for Ipsos. Ipsos shares have had a mixed year, with a 30 day share price return of 13.64% and a 1 year total shareholder return of 9.69%, which signals momentum building again after recent leadership and earnings news. If this kind of leadership change has you thinking...

Why Getlink’s Latest Half Year Earnings Matter For Investors Getlink (ENXTPA:GET) has drawn fresh attention after reporting half year 2026 earnings, with sales and revenue of €824 million and net income of €118 million, compared with the prior year period. See our latest analysis for Getlink. Despite some minor daily fluctuations, Getlink’s share price has a year to date return of 16.53%, while the 1 year total shareholder return of 18.75% reflects recent performance. If Getlink’s results...

Nexans S.A. recently reported past half-year 2026 results showing sales rising to €4,736 million from €3,977 million, while net income fell to €103 million from €372 million and earnings per share also decreased versus a year earlier. At the same time, the company confirmed it is actively pursuing mergers and acquisitions as part of its profitable growth plan, underpinned by refreshed board committee roles with high levels of director independence. Now we’ll examine how Nexans’ higher sales...

Veolia Environnement (ENXTPA:VIE) is in focus after securing a long term water and sanitation contract in Cúcuta, Colombia, alongside reporting half year 2026 results and reaffirming its 2026 dividend guidance. See our latest analysis for Veolia Environnement. At a share price of €34.98, Veolia Environnement has delivered a 16.06% year to date share price return, supported by the Cúcuta contract, half year 2026 earnings and reaffirmed 2026 dividend guidance. Its 1 year total shareholder...

In late July 2026, the European Commission approved Sanofi’s MenQuadfi meningococcal vaccine for use in EU infants from six weeks of age, extending coverage against serogroups A, C, W, and Y and aligning dosing with routine pediatric schedules. This broadened indication gives Sanofi an earlier entry point into infant immunization programs, potentially deepening its vaccines footprint in a high‑need, high‑risk population. Next, we’ll examine how gaining infant approval for MenQuadfi across...